Melanoma Nursing Webinar Program
Accessing anti-cancer medications in Australia and personalising treatment decision-making in melanoma
This webinar was held on 16 December, 2025
This webinar is tailored for melanoma nurses aiming to deepen their understanding of medication access and decision making.
This session explored the different ways medications are accessed in Australia including information about the Pharmaceutical Benefit Scheme and Therapeutic Goods Administration, introduce the concept of personalised medicine, and discuss treatment decision making for stage 2, 3 and advanced melanoma. Nurses will gain insights into treatment decision pathways and how therapies are selected based on patient specific factors such as financial ability, assessments of survival, treatment availability and their side effect and toxicity profiles, equipping them with the knowledge to offer comprehensive care and patient education as critical members of the multidisciplinary team.
Learning outcomes:
- Understand medication access in Australia
- Comprehend personalised medicine
- Analyse treatment decision pathways
- Apply knowledge to patient education
Audience: Cancer nurses
Speakers
 |
Dr Piyush Grover Dr Piyush Grover is a Medical Oncologist at Fiona Stanley Hospital and Sir Charles Gairdner Hospital with a focus on melanoma, upper gastrointestinal cancers, neuroendocrine tumours and immuno-oncology. Piyush moved to Perth from New Zealand to study medicine at the University of Notre Dame and graduated with First Class Honours. He completed physician training at various Perth Hospitals before undertaking a clinical and research fellowship at the Melanoma Institute Australia. On returning to Western Australia, he undertook the WA Cancer and Palliative Care Network research fellowship and is pursuing a PhD in Immuno-Oncology. Prior to medicine, he worked as a clinical pharmacist and was the runner-up for New Zealand’s Young Pharmacist of the Year in 2011. |
|
Chair: Kathe Holmes
|
Resource details
This course is brought to you by
